Skip to main content
SpringerLink
Log in
Book cover

Sandostatin® in the Treatment of Acromegaly

Consensus Round Table, Amsterdam 1987

  • Conference proceedings
  • © 1988

Overview

Editors:
  1. Steven W. J. Lamberts

    1. Rotterdam, University Hospital, Dijkzigt, Rotterdam, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (29 papers)

  1. Front Matter

    Pages I-X
    Download chapter PDF

  2. Clinical Aspects of Growth Hormone Hypersecretory States

    • M. O. Thorner, M. L. Hartman, M. L. Vance
    Pages 1-7

  3. Correlation Between Preoperative Testing and Tumour Morphology in Acromegaly

    • D. Killinger, J. Gonzalez, E. Horvath, K. Kovacs, H. Smyth
    Pages 9-16

  4. Acromegaly: Objectives of Therapy

    • H.-J. Quabbe
    Pages 17-22

  5. Surgical Treatment of Acromegaly

    • A. M. Landolt, R. Illig, J. Zapt
    Pages 23-35

  6. External Radiation Therapy of Acromegaly

    • J. A. H. Wass, E. Ciccarelli, S. Corsello, G. M. Besser, N. Plowman, A. E. Jones
    Pages 37-43

  7. Bromocriptine Treatment of Acromegaly

    • K. von Werder
    Pages 45-52

  8. Chemical Structure, Pharmacodynamic Profile and Pharmacokinetics of SMS 201–995 (Sandostatin®)

    • P. Marbach, H. Andres, M. Azria, W. Bauer, U. Briner, K.-H. Buchheit et al.
    Pages 53-60

  9. Studies on the Acute and Chronic Effects of Sandostatin® in Acromegaly

    • S. W. J. Lamberts
    Pages 61-74

  10. Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin

    • A. Liuzzi, P. G. Chiodini, R. Cozzi, D. Dallabonzana, G. Oppizzi, M. M. Petroncini
    Pages 75-79

  11. Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995 (Sandostatin®)

    • H.-J. Quabbe, U. Plöckinger
    Pages 81-82

  12. Observations During a Clinical Trial of Sandostatin® in Acromegalic Patients

    • H. Ørskov, J. Weeke, S. E. Christensen, S. Nielsen, A. Flyvbjerg, J. O. L. Jørgensen et al.
    Pages 83-87

  13. Effects of Long-Term Administration of Sandostatin® (SMS 201–995) at Increasing Doses in 40 Acromegalic Patients. Results from the French Sandostatin Acromegaly Study Group

    • G. Sassolas, P. Fossati, P. Chanson, R. Costa, B. Estour, A. Deidier et al.
    Pages 89-94

  14. Experience with Sandostatin® in Various Groups of Acromegalic Patients

    • A. Stevenaert, A. Beckers, K. Kovacs, E. Bastings, M. de Longueville, G. Hennen
    Pages 95-101

  15. Treatment of Acromegaly with SMS 201–995 (Sandostatin®): Clinical, Biochemical and Morphologic Study

    • A. L. Barkan, R. V. Lloyd, W. F. Chandler, M. K. Hatfield, S. S. Gebarski, R. P. Kelch et al.
    Pages 103-108

  16. Long-Term Treatment of Acromegaly by Continuous Subcutaneous Infusion of the Long-Acting Somatostatin Analog Sandostatin® (SMS 201–995, Octreotide)

    • J. P. Tauber, Th. Babin, M. C. R. Ducasse, M. T. Tauber, A. G. Harris, F. Bayard
    Pages 109-112

  17. Sandostatin® (SMS 201–995) Treatment of Acromegaly: Acute and Chronic Effects

    • S. R. George
    Pages 113-115

  18. Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group

    • A. G. Harris, H. Prestele, K. Herold, V. Boerlin
    Pages 117-125

  19. Pulsatile Administration of SMS 201–995 (Sandostatin®) in the Treatment of Acromegaly

    • H. Imura, Y. Kato, N. Hattori
    Pages 127-128

  20. Treatment of Acromegaly with SMS 201–995 (Sandostatin®): A Collaborative Study in Japan

    • H. Imura, M. Irie
    Pages 129-131
Back to top

Keywords

About this book

Acromegaly is a relatively rare chronic disease. Nevertheless, it is life-threatening in its sequelae, for example, hypertension and cardiovascular disease. Since it also has disfiguring properties - especially of the head and face - acromegaly has serious psychological consequences which are reinforced by the awareness of factors such as excessive sweating. It is precisely on these signs and symptoms that Sandostatin R has a rapid effect, thus improving the patient's quality of life as well as counteracting the underlying processes. SandostatinÊ

Editors and Affiliations

  • Rotterdam, University Hospital, Dijkzigt, Rotterdam, The Netherlands

    Steven W. J. Lamberts

Bibliographic Information

  • Book Title: Sandostatin® in the Treatment of Acromegaly

  • Book Subtitle: Consensus Round Table, Amsterdam 1987

  • Editors: Steven W. J. Lamberts

  • DOI: https://doi.org/10.1007/978-3-642-73694-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag, Berlin Heidelberg 1988

  • Softcover ISBN: 978-3-642-73696-4Published: 16 January 2012

  • eBook ISBN: 978-3-642-73694-0Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: X, 171

  • Number of Illustrations: 10 b/w illustrations

  • Topics: Endocrinology, Pharmacology/Toxicology, Neurosciences

Publish with us

Policies and ethics

Back to top

Search

Navigation